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TObjective: Perioperative hypothermia might be detrimental to the patient undergoing
off-pump coronary artery bypass surgery. We assessed the efficacy of the Allon
thermoregulation system (MTRE Advanced Technologies Ltd, Or-Akiva, Israel)
compared with that of routine thermal care in maintaining normothermia during and
after off-pump coronary artery bypass surgery.
Methods: Patients undergoing off-pump coronary artery bypass surgery were perio-
peratively and randomly warmed with the 2 techniques (n  45 per group). Core
temperature, hemodynamics, and troponin I, interleukin 6, interleukin 8, and inter-
leukin 10 blood levels were assessed.
Results: The mean temperature of the patients in the Allon thermoregulation system
group (AT group) was significantly (P  .005) higher than that of the patients
receiving routine thermal care (the RTC group); less than 40% of the latter reached
36°C compared with 100% of the former. The cardiac index was higher and the
systemic vascular resistance was lower (P  .05) by 16% and 25%, respectively, in
the individuals in the AT group compared with in the individuals in the RTC group
during the 4 postoperative hours. End-of-surgery interleukin 6 levels and 24-hour
postoperative troponin I levels were significantly (P  .01) lower in the patients in
the AT group than in the RTC group. The RTC group’s troponin levels closely
correlated with their interleukin 6 levels at the end of the operation (R  0.51, P 
.002).
Conclusions: Unlike routine thermal care, the Allon thermoregulation system main-
tains core normothermia in more than 80% of patients undergoing off-pump coro-
nary artery bypass surgery. Normothermia is associated with better cardiac and
vascular conditions, a lower cardiac injury rate, and a lower inflammatory response.
The close correlation between the increased interleukin 6 and troponin I levels in the
routine thermal care group indicates a potential deleterious effect of lowered
temperature on the patient’s outcome.
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CSPMild perioperative hypothermia (1°C-2°C less thanthe normal core body temperature) is common inalmost any major operation, occurring in 50% to
75% of the patients.1 It results from anesthesia-induced
impairment of thermoregulation,2 exposure to a cold ambi-
ent, and altered distribution of body heat.3 Several investi-
gators demonstrated that perioperative hypothermia alters
the immune system function and therefore increases the
body’s susceptibility to comorbidity.4,5
Warming of patients undergoing surgical intervention is
mostly achieved by conventional means, such as routine ther-
mal care (RTC), consisting of drapes, the infusion of warm
(38°C) fluids, or the ejecting of warm (38°C) air over the body.
The minimizing of evaporation from the airways by introduc-
ing the Bact Hme Port (Pharma Systems AB, Knivsta, Swe-
den) between the endotracheal tube and the ventilator itself
might also be used for such purposes. The Allon thermoregu-
lation system (AT; MTRE Advanced Technologies Ltd, Or-
Akiva, Israel) represents an advanced technology of patient
warming that has been recently applied in the operating room
(OR) and described by us in detail previously.6
The use of cardiopulmonary bypass (CPB) is associated
with a systemic inflammatory response because of its exposure
to a large foreign-body surface area.7,8 Systemic immune re-
sponse syndrome and reperfusion injury of the heart reflect the
possible clinical effect of this massive activation of the im-
mune system. Inflammatory cytokines, such as interleukin (IL)
6, IL-8, and the anti-inflammatory cytokine IL-10 are thus
activated and released during the operation.7,8 Independently
of CPB, there is also a general activation of the immune system
during any surgical procedure, representing a physiologic re-
sponse to surgical stress and trauma.5
Until recently, the level of response of the immune
response system associated with cardiac surgery was attrib-
uted predominantly to the use of CPB,9 but comparative
data on the effects of CPB on this system to the response
evoked by surgical trauma per se are scant. Notably, the
immune response to surgical stress, trauma, or both, might
be exacerbated by body hypothermia.10
The aims of the current study were (1) to evaluate the
efficacy of the AT system versus the RTC methods in main-




MABP (mm Hg) 91.4 12.3 8
HR (beats/min) 88.6 8.0 8
CK-MB mass (g/L) 1.2 6.3
Troponin I (ng/mL) 0.4 1.61372 The Journal of Thoracic and Cardiovascular Surgery ● Juntaining normothermia in patients undergoing off-pump coro-
nary artery bypass surgery (OPCAB) and (2) to measure the
effect of each technique with other characteristics observed
during OPCAB, such as hemodynamic and myocardial
changes and variations of the immune response system.
Patients and Methods
This randomized, prospective, open-labeled, multicenter investi-
gation involved patients of the Tel-Aviv Sourasky Medical Center,
Tel Aviv, Israel; the Cleveland Clinic Foundation, Cleveland,
Ohio; and the Centre Cardiologie du Nord, Paris, France.
Patient Enrollment
The study was approved by the ethics committees of the partici-
pating centers, and each patient signed an approved informed
consent form. Entrance criteria were a patient’s first-time referral
for isolated coronary bypass surgery and a technically feasible
OPCAB in that patient. Patients were excluded in cases of emer-
TABLE 1. Demographic and medical characteristics and
surgical data (n  45 per group)
Parameter AT group RTC group
Age (y) 69.2 17.1 68.2  12.6
Male sex (n) 32 (70) 24 (52)
Weight (kg) 73.5 7.4 68.2  15.0
Height (cm) 167.5 8.6 164.6  9.9
Body surface area (m2) 1.87 5.2 1.82  0.7
Body mass index (kg/m2) 26.9 2.6 24.9  5.6
Hypercholesterolemia (n) 32 (70) 22 (48)
Hypertension (n) 34 (75) 18 (40)
Diabetes (n) 21 (49) 26 (52)
Serum creatinine 1.5-2 mg/dL 2 (4) 3 (6)
Peripheral vascular disease (n) 7 (15) 5 (12)
Previous CVA (n) 3 (7) 2 (4.5)
Past history of smoking (n) 22 (48) 26 (52)
EuroSCORE 2.9 (0.9-8.2) 3.2 (2.0-9.9)
Duration of the operation (min) 218.0 96.2 228.2  62.8
Bypass grafts (n) 2.1 0.5 2.2  0.6
Values are presented as means  SD, median (range), or absolute value
(percentage) where shown. There were no statistically significant differ-
ences between the groups for all reported data. AT, Allon thermoregulation
system; RTC, routine thermal care; CVA, cerebrovascular accident.
45 per group)
30 min into the operation
C AT RTC
16.3 82.5 13.4 85.6 15.3
15.0 87.0 11.0 84.6 9.0
3.6 2.1  2.8 3.4  7.6
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Pgency or concomitant valvular surgery, Q-wave myocardial infarc-
tion during the previous 3 weeks, poor left ventricular function (ie,
ejection fraction 30%), body mass index of greater than 35
kg/m2, extensive dermopathy (including past skin burns), and
chronic renal failure requiring dialysis. Also excluded were pa-
tients with clotting abnormalities (eg, prothrombin time, 60
seconds; partial thromboplastin time, more than twice the normal
range), platelets of less than 70,000/mm3, white blood cells of less
than 3000/greater than 14,000, uncontrolled diabetes (fasting glu-
cose level 250 g/dL), evidence of sepsis or of any type of
infection within a week before screening, or evidence of endocri-
nopathy or the use of endocrine replacement substances. There was
no age restriction.
Group Assignment
Patients who met the OPCAB criteria (see below) were random-
ized by a computer-generated random-number table to the AT or
RTC group on the day of the operation. The study design was not
blinded intraoperatively because of the application of the different
warming devices, but it was blinded to the surgeons who assigned
the patients to OPCAB versus CPB, as well as to the postoperative
ward nursing staff. Demographic and clinical preoperative char-
acteristics were later used to calculate the EuroSCORE (European
System for Cardiac Operation Risk Evaluation, ranging between 1
and 15) for each participant.
Patient Selection for OPCAB and Later Exclusion
Criteria
Potential study patients also needed to meet the criteria for under-
going an OPCAB procedure. Each center was staffed by an inde-
pendent surgeon experienced in OPCAB who decided who would
be suitable for such a procedure on the basis of routine institutional
policy (eg, which vessel needed revascularization) and who was
considered a suitable candidate for CPB (eg, existence of very
small coronary vessels). Intraoperative conversion to CPB could
be carried out if hemodynamic stability could not be achieved
despite aggressive efforts (ie, fluid or catecholamine administra-
tion) or if the coronary vessels turned out to be unsuitable for
OPCAB (eg, small and atheromatous, calcified, or deeply in-
tramyocardial). Patients were excluded from the study if the tem-
perature in the OR was less than 17°C or greater than 19°C during
the time of the operation. The above patients were subsequently
replaced by others.
Other exclusions (not replaced) were patients who bled post-
operatively and required reoperation within 4 hours after the
End of anastomoses End of t
AT RTC AT
90.1 14.3 92.4 9.6 88.6 16.5
86.0 17.0 78.0 12.0 91.0 9.0
2.4  3.6 8.0 18.9 4.2 4.7
1.4  3.4 1.9 2.3 4.7 6.4
Values are presented as means SD. There were no statistically signific
period (by ANOVA with repeated measures). AT, Allon thermoregulation sy
rate; CK-MB, creatine kinase myocardial fraction. *P  .05, †P  .01 (byThe Journal of Thoracicoperation, those who underwent perioperative myocardial infarc-
tion (MI) diagnosed on the basis of an immediate postoperative
hemodynamic instability and later supported by a new Q-wave on
the electrocardiogram, or those whose serum total creatine kinase
(CK) levels increased more than 5-fold greater than the upper limit
associated with an MB fraction of greater than 6%. Finally, pa-
tients who experienced a late postoperative MI confirmed on the
basis of positive coronary angiography were dropped from the
study.
The data of patients who bled after the first 4 postoperative
hours and underwent reoperation were not replaced by the data of
other patients. Their demographic and intraoperative data were
included in the cohort information (by using the intent-to-analyze
test), with the distinction that the bleeding and blood replacement
data of these patients was not included in the cohort data.
Patient-Warming Modalities
The OR temperature was kept between 17°C and 19°C. Warming
of the patients in each group was initiated before the induction of
anesthesia and was continued throughout the operation and for the
following 2 hours in the intensive cardiac care unit (ICCU). The
Allon system that was used in the AT study group consists of 3
elements: a microprocessor-controlled heating-cooling unit, body
temperature sensors (ie, core [rectal] and skin thermistors), and a
specially designed garment that wraps around the patient.6 Con-
tinuous monitoring of the patient’s rectal and skin temperature is
performed with the thermistors. All skin temperature measure-
ments are recorded with 2 skin sensors. A feedback-controlled
microprocessor unit receives the data from the rectal thermistor,
which serves as the afferent arm. Water is then circulated by a
pump and is controlled and maintained at a set point ranging from
18°C to 39.5°C in a closed loop between the garment and the unit.
Water temperature is continuously adjusted through the feedback
loop to reach a predetermined temperature.
The garment is composed of a 2-layer plastic biocompatible
material approved by the US Food and Drug Administration. The
outer layer is made of nonwoven polypropylene material, and the
inner layer is made of polyethylene. The specially designed gar-
ment wraps around the patient’s body over the entire area of the
back, the sides of the body to the midclavicular line, and the
shoulders and legs in a way that it does not interfere with the
surgical field. Water flows between the 2 layers, transferring
controlled heat throughout the operation. This water is the actual
heat exchanger, being the garment the only component in direct
contact with the patient’s skin surface. All of the garment’s com-
eration 4 h postoperatively
RTC AT RTC
85.5 13.2 87.3 19.2 84.6 14.7
88.0 12.0 103.0 12.0 95.0 12.0
11.1 19.9* 17.8 26.6 23.2 40.1
13.8 3.7† 8.1 21.4 19.4 3.7*
ifferences between the groups for all reported data throughout the study
RTC, routine thermal care; MABP, mean arterial blood pressure; HR, heart
t) versus the AT group.he op
ant d
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CSPponents are made of disposable materials. It is puncture resistant
and reusable and can be sterilized.
All patients in the RTC group were warmed with a combination
of water blankets (Thermostat T1000; JMW Medical Systems Ltd,
Midlothian, United Kingdom) and intravenous fluid warmers (Fen-
wal model BW5, Deerfield, Ill) from the time of induction of
anesthesia throughout the entire perioperative period and an air
warmer (38°C; Thermacare; Gaymar Industries Inc, Orchard Park,
NY). After the termination of the operation, these patients were
covered with convective air warmers (Bair Hugger cardiac blan-
ket; Augustine Medical Inc, Eden Prairie, Minn) and warm blan-
kets until the end of the postoperative phase of the analysis.
Anesthesia Protocol
Induction of standard anesthesia consisted of 2 mg of midazo-
lam, 1 mg/kg propofol, medium-dose fentanyl (5-15 g/kg),
and pancuronium (1.5 mg/kg), followed by endotracheal intu-
bation. Anesthesia was maintained by infusions of the 2 latter
drugs, and dose changes were carried out to keep the patient
adequately anesthetized and hemodynamically stable. All pa-
tients were ventilated by using oxygen with volume-preset
time-cycled ventilators (10 mL/kg tidal volume); isoflurane
(0.4%-0.8% inspired concentration) was used as deemed nec-
essary to the attending anesthetist. Catecholamines and nitrites
were given by the attending anesthetist up to 24 hours postop-
eratively, as deemed necessary.
Surgical Procedures
OPCAB was performed through a midline sternotomy, followed
by partial heparinization, with the left internal thoracic artery and
(occasionally) the right internal thoracic artery, the radial artery,
and/or the saphenous veins as conduits.
Mechanical stability of the coronary arteriotomy areas was
Figure 1. Core (upper graph) and skin (lower graph) tempera-
tures. Temperatures were constant or augmented in the Allon
Thermoregulation system group but decreased over most of the
surgical period in the RTC group. *P< .001; †P< .003 (by ANOVA)
between the groups.achieved with the Octopus II (Medtronic Inc, Minneapolis, Minn).
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done after the distal anastomoses were carried out with a partial
clamp. Reversal of heparinization was implemented only when
there was evidence of a bleeding tendency: doses of protamine
sulfate (50 mg per dose) were added if the activated clotting time
was greater than 50% of the patient’s baseline measurement, if
clots were not detected within the operating field, or both. Nitro-
glycerin and dopamine were administered ad hoc, as deemed
necessary by the surgeon.
Assessment of Vital Signs
Perioperative monitoring of vital signs followed standard institu-
tional protocols. These consisted of 2-surface electrocardiographic
leads, an intraradial arterial line, pulse oximetry, end-tidal CO2,
and a Swan-Ganz pulmonary artery catheter (Baxter Vigilance
Monitor Model VGS; Baxter Healthcare Corp, Irvine, Calif).
These devices enabled direct assessment of heart rate, invasive
blood pressures, pulmonary artery and wedge pressures, cardiac
output and cardiac index (CI; in L · min1 · m2), and systemic
vascular resistance (SVR; in dynes · s1 · cm5). Urinary bladder
and skin temperatures were also continuously measured.
Blood Loss and Replacement
On completion of the operation, the patients were transferred to the
ICCU, where they were allowed to wake up when they became
hemodynamically stable and when blood loss from the chest drain
reached less than 100 mL/h. They were given packed red blood
cells only if the hemoglobin concentration was less than 8 mg/dL
or if patients showed hemodynamic instability when the hemoglo-
bin concentration was 8 to 10 g/dL. Patients with apparent volume
depletion received crystalloid solutions.
Re-exploration was performed if blood was drained at a rate
more than 400 mL during the first postoperative hour or greater
than 200 mL/h for more than 4 hours postoperatively. The chest
tube was withdrawn within 24 hours after the operation or when
the amount of drained blood was less than 200 mL/d. Patients were
discharged from the ICCU to the ward when they were fully
awake, hemodynamically stable, and had minimal chest tube
drainage.
Cardiac Protein and Cytokine Measurements
Perioperative ischemic myocardial injury was assessed by deter-
mining serum levels of total CK-MB mass fraction and troponin I.
Immunologic changes were assessed by measuring IL-6, IL-8, and
IL-10 levels in the serum.
Blood samples were collected at the time of induction of
anesthesia, after sternotomy, at the completion of the anastomoses,
at the end of the operation, and 6 and 24 hours later. For cytokine
measurements, blood samples were collected twice, once at the
time of induction of anesthesia and again at the end of the oper-
ation. Serum separation was performed immediately after blood
removal, and samples were kept at 70°C until analyzed. Serum
troponin I (physiologic range, 0.5 ng/mL) and CK-MB mass
(physiologic range,30 IU/L) levels were determined by using an
immunoassay method (microparticle enzyme immunochemical as-
say; Abbott Axsym System, Abbott, Italy). The cytokines were
assessed by using an enzyme-linked immunoabsorbent assay with
human IL-6, IL-8, and IL-10 ultrasensitive kits (Bio Source Int,
e 2005
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PCamarillo, Calif). All factors were analyzed in the Karolinska
Hospital Clinical Chemistry Department, Stockholm, Sweden.
Statistical Analysis
The sample size (45 patients per group) was the result of a power
table calculation on the basis of a 5% difference between the
groups (  .05), an average of a 2°C difference between group
temperatures (  2), and an 80% power to detect a 5% difference
(1.8°C) of the 36.0°C optimal temperature. Demographic and
background values of the patients (ie, age, weight, anesthetic, and
baseline temperature and vital signs) were compared with 1-way
analyses of variance (ANOVAs). The data of all patients who were
dropped from the cohort after the operation had started were
evaluated by the intent-to-treat test. ANOVA with repeated mea-
sures was used to determine changes in temperature trends, vital
signs, and troponin I levels throughout the study period. The mean
values of the intraoperative and postoperative temperatures at the
determined time points and the total number of grafts were com-
pared by the paired t test. The same test was used to analyze
differences in mean vital signs and troponin I protein levels be-
tween the 2 groups. The nonparametric Mann-Whitney rank test
was used to determine differences in IL-6, IL-8, and IL-10 levels,
as well as in EuroSCOREs. The Spearman correlation coefficient
was applied to determine the grade of correlation between various
ILs and troponin I within each group. The 2 and Fisher exact tests
were used to analyze categoric data (eg, type of grafts). All
ANOVA tests were followed by the post-hoc Tukey test. All
values are presented as means  SD.
Results
Of the 90 patients who were prospectively and randomly
enrolled in the study, 5 were excluded postoperatively. One
patient in each group underwent reoperation within less than
4 postoperative hours as a result of postoperative bleeding.
One patient in each group was also excluded because of
undergoing operations during an undiagnosed acute MI:
they both demonstrated high levels of cardiac enzymes
Figure 2. Temperature distribution. The percentage o
reached 36°C or more is shown. *P < .001 (by ANOVAthroughout the study period. The fifth patient was excluded
The Journal of Thoracicfrom the RTC group because of a perioperative MI induced
by means of acute occlusion of an anastomosis that was
later visualized angiographically.
Two patients in the RTC group and 3 patients in the AT
group underwent reoperation for postoperative bleeding
tients in each study group whose core temperature
tween the groups.
Figure 3. SVR (lower plain) and CI (upper plain). SVR increased
and CI decreased in the RTC group but remained stable in the
Allon Thermoregulation system group. *P < .001; †P < .01 (by
ANOVA) between the groups.f pa
) bemore than 4 hours after the operation; their background and
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CSPdemographic data were therefore included in the cohort
presentation but not in the assessments of specific blood loss
and replacement. Finally, 7 patients were converted from
OPCAB to CPB during the operation, and they were re-
placed by 7 other patients undergoing OPCAB.
The demographic and the preoperative clinical data of
the participants revealed no significant differences between
the 2 groups (Table 1 and data not shown, respectively). The
calculated EuroSCOREs were also similar between the
groups (Table 1).
Perioperative Data
Respiratory data and the amounts of the anesthetic agents
used during the operation were similar in both groups (data
not shown). The total number of grafts was also similar
between the groups (Table 1), as were the graft types
(skeletonized left or right internal thoracic artery, radial
artery, or saphenous vein; data not shown). The total OR
time was also similar (Table 1), as was the differential
postischemia OR time (AT group, 46  10 minutes; RTC
group, 51  9 minutes; P  .08).
Table 2 displays the perioperative trends in the patients’
blood pressures and heart rates: they did not change perio-
peratively. The 24-hour values were not different between
the groups (data not shown). Both the core and skin tem-
peratures (Figure 1) were constantly higher in the AT group
compared with those in the RTC group (P  .05 after
sternotomy and P  .001 at the end of the operation, t test).
Overall, skin temperature in patients receiving AT recuper-
ated slowly but constantly; it did not in the individuals
receiving RTC. Figure 2 shows the percentage of patients in
each group who attained normothermia (36.0°C): less
than 40% of the patients in the RTC group versus 100% of
the patients in the AT group (P  .001).
The SVR values were not different between the groups
during the operation. They were, however, significantly






Mortality (30 d)* 1 0
Atrial fibrillation 15 (33) 17 (35)
Cerebrovascular attack† 0 1
New-onset renal failure
By creatine clearance test 2 3
Requiring dialysis 0 1
Pleural effusion or pneumothorax 3 2
Infection requiring antibiotic therapy 5 4
Data are presented as the number of patients (percentage). There were no
statistically significant differences between the groups for the reported
data. AT, Allon thermoregulation system; RTC, routine thermal care.
*Caused by cardiac arrest. †Transient or permanent.lower (P  .01, ANOVA, group effect) starting at the end
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hours in the AT group compared with in the RTC group
(Figure 3, lower plane). After this period, the SVR values of
the 2 groups became similar again. The mean CI was also
significantly (P  .05, ANOVA, group effect) higher in the
AT group than in the RTC group starting at the end of the
operation and lasting to the end of the study period (Figure
3, upper plane).
Hourly chest tube output was similar between the 2
groups (data not shown). The number of blood cell units
required in the AT group was similar to that in the RTC
group (AT group, 1.3 3.5; RTC group, 2.2 1.5; P .1).
Crystalloids were administered to a similar extent (data not
shown). The total amounts of dopamine and nitroglycerin
administered to the patients were similar for the 2 groups
both intraoperatively (26.6  18.7 [AT] and 27.7  12.6
mg [RTC], P  1.0; 12.6  17.8 [AT], 16.7  11.9 mg
[RTC], P  .9, respectively) and postoperatively (126.8 
73.3 [AT], 133.5  89.9 mg [RTC], P  1.0; 49.6  51.8
[AT], 56.6  72.9 mg [RTC], P  .90, respectively).
Time to extubation of the patients was significantly
shorter in the AT group (7.0  3.4 hours postoperatively)
than in the RTC group (11.4  7.1 hours, P  .01). The
length of hospital stay was not statistically different be-
tween the groups (5.6  4.0 days [AT], 7.2  11.2 days
[RTC], respectively; P .28) nor was the time to discharge.
The rates of postoperative complications were similar be-
tween the groups (Table 3).
Cardiac Protein and Cytokine Profiles
The overall serum CK-MB mass fraction and troponin I
levels were comparable between the 2 study groups at the
time of anesthesia induction and throughout the operation.
The CK-MB values increased sharply immediately after the
end of the operation in both groups and remained similarly
increased throughout the study (Table 2) and up to 24 hours
postoperatively (data not shown). In contrast, the troponin
values increased at the end of the operation, especially in the
RTC group, and remained unaltered for 4 hours (Table 2),
as well as for 24 hours (data not shown).
The profiles of the tested cytokines are illustrated in
Figure 4. Serum IL-6, IL-8, and IL-10 levels were signifi-
cantly higher at the end of the operation in both the RTC
and AT groups compared with their own values at the time
of the induction of anesthesia (baseline); only the IL-6
values, however, were significantly lower in the AT group
compared with those in the RTC group (Figure 4).
There was a direct correlation between the individual’s
duration of surgical intervention and the troponin I (R 
0.64, P  .002), IL-6 (R  0.84, P  .0001), IL-8 (R 
0.68, P  .0001), and IL-10 (R  0.6, P  .001) levels.
Also, the IL-6 plasma levels directly correlated with the
troponin values at the end of the operation in both groups (R
e 2005
Nesher et al Cardiopulmonary Support and Physiology
CS
P 0.51, P  .004) but not with the IL-8 or IL-10 values (R
 0.33, P  .07; R  0.35, P  .08, respectively).
Discussion
Our current results show that stable normothermic condi-
tions were maintained and even enhanced in the AT group
during the entire OPCAB study period compared with the
failure to reach the target value of 36°C in the RTC group.
Both groups had a systemic flare-up of the postoperative
immune response, as expressed by an increase of proinflam-
matory cytokines (IL-6 and IL-8) and of the anti-inflamma-
tory cytokine IL-10. A better controlled immune response
(lower values of IL-6), superior hemodynamic conditions
(increased CI and decreased SVR), and minimal myocardial
injury were achieved in the normothermic AT group com-
pared with in the hypothermic RTC group.
Although it is rarely desired, and in spite of inexpensive
and safe methods of warming, mild perioperative hypother-
mia (approximately 2°C less than the normal core body
temperature) is a common occurrence in most major surgi-
cal procedures, accounting for 50% to 75% of all surgical
patients.1 It results from anesthetic-induced impaired ther-
moregulation,2 exposure to a cold ambient, and altered
distribution of body heat.3 These factors were similar be-
tween the 2 groups in the current study.
It is currently held that mild-to-moderate hypothermia
during cardiac surgery plays a protective role in preventing
myocardial damage by reducing oxygen consumption,
mainly in the heart.11 Our data might contradict this con-
viction and suggest that the protective role of hypothermia
might not bestow any benefit in patients undergoing OP-
CAB. Indeed, there is no need to reduce a patient’s core
temperature during OPCAB surgery, even to the mild level
of hypothermia that was thought to be desirable when CPB
is conducted.1 AT was also associated with reduced levels
Figure 4. Preoperative and postoperative IL levels. A
groups. *P  .0001 (by t test) versus the correspondinof IL-6 and troponin and with improved hemodynamics,
The Journal of Thoracicfindings that suggest that normothermia is closely related to
reduced inflammatory responses to stress and subsequently
to a lower rate of myocardial damage. This latter finding
was unexpected and one that we believe has not been
reported before.
Until recently, the systemic immune response associated
with cardiac surgery was attributed predominantly to the use
of CPB.7,8,12 A clear correlation was also shown to exist
between the duration of the operation and crossclamp time
and IL levels,13,14 and the activation of the immune system
is a physiologic response to stress and trauma.15 Our data
support the abovementioned conclusion that most of the
observed immune response was attributable to the surgical
trauma per se rather than to CPB. Nevertheless, because the
IL-6 level was lower in our AT group, we further suggest
that patient body temperature played a role in modulating
the inflammatory response as well.
The increased troponin I and cytokine levels that were
recorded in the RTC group and the unexpected direct cor-
relation between IL-6 and troponin levels deserve a separate
mention. We suggest that the hypothermic group sustained
more extensive myocardial damage that correlated directly
with IL-6. We chose to assess troponin, a specific marker of
myocardial injury, because it had been previously used to
detect perioperative myocardial damage after CABG sur-
gery.6,16 Because this correlation was minimal in the AT
group, our results indicate that proinflammatory cytokines
appear to exert an additive damaging effect on the myocar-
dium in the presence of hypothermic conditions.
IL-6 was found to be released from vascular smooth
muscle cells and to stimulate the induction of endogenous
platelet-activated growth factor, which causes a significant
increase of intracellular calcium levels and subsequent va-
soconstriction.17 Recent studies have also shown that the
release of IL-6 from vascular smooth muscle cells might be
levels increased by the end of the operation in both
eline values; †P  .008 versus the RTC group.ll IL
g bastriggered or induced by potent vasoconstrictors, such as
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CSPangiotensin II,18 endothelin,19 serotonin,20 and norepineph-
rine.21 Increased serum IL-6 levels might thus reflect an
increase in the adrenergic drive and therefore might be
related to SVR changes, but we could not explore this aspect
or the relevance of increased IL-6 levels to postoperative
complications because vasoactive drugs were used similarly
in both of our study groups.
There are several limitations to this study. Although the
results are meaningful statistically, a larger cohort would
probably better reflect the differences between the conven-
tional and the new warming technologies. A second limita-
tion is that ours were relatively low-risk patients, and high-
risk subjects might have better differentiated between the
parameters we examined. Because this study was under-
taken in 3 different centers, it represents their combined
complication rates, although the immediate outcome after
OPCAB surgery varied very little from the rate of compli-
cations reported by others.22,23 In addition, we did not look
at the rate of metabolism and elimination of the tested
cytokines and enzyme, and therefore we could not prove
that the high serum troponin level is attributable to cardiac
injury alone. Although a reduced metabolic rate, such as
that occurring during hypothermia, should decrease the pro-
duction of both the cytokines and troponin, the serum levels
of these compounds were higher during low, but not high,
body temperatures, indicating the presence of cardiac dam-
age. We did not conduct cost-effective analyses of the
thermo-wrap garment, but it is reasonable to assume that
any acceleration of recovery time and earlier discharge from
the ICCU will produce economic benefits. Finally, data on
patients who underwent thoracostomy would have been
especially relevant to the current study, but this procedure is
not performed in any of the 3 participating centers.
In conclusion, normalization of the two physiologically
balanced pathways of inflammatory and anti-inflammatory
responses after OBCAB surgery was in part caused by
normothermia. Although group differences in IL-8 and
IL-10 did not reach the level of statistical significance, we
speculate that they might have done so and that they would
have had a more pronounced clinical effect in a larger
cohort, thereby further enhancing patient outcome after
OPCAB and possibly other heart operations.
We thank Esther Eshkol, MA, institutional medical and scien-
tific copyeditor, Tel Aviv Sourasky Medical Center, for editorial
assistance.
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